Ïã¸ÛÁùºÏ²ÊÐþ»ú

Skip to main content

Surprising reason that B cells benefit from booster shots

New research solves the mystery of how two different types B cells work in tandem to fight off re-infections, with implications for vaccine boosting strategies.

Could a bout of COVID protect you from a severe case of flu?

New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity—and potentially better pandemic preparedness.

Rockefeller launches new introductory curriculum for graduate students

The new programming, which spans the full month of September, is designed to teach essential skills and ground students in different research opportunities before lab rotations begin.

Alexander Tomasz, a trailblazer in the study of multidrug-resistant microbes, has died

His work has been crucial for the development of new antibiotics, which are urgently needed in a world where multi-resistant superbugs are a major threat to public health.

Svetlana Mojsov wins the 2024 Lasker~DeBakey Clinical Medical Research Award

Mojsov’s discovery of GLP-1 and its critical role in the regulation of insulin secretion and blood glucose led to the development of a revolutionary new class of medicines.

Rockefeller University surpasses new federal safeguards for volunteers in clinical research

The Association for the Accreditation of Human Research Protection Programs once again commended Rockefeller’s standards and practices.ÌýÌý

Why a promising breast cancer drug doesn’t work—and how to improve it

A treatment that appears effective in cancers such as myelofibrosis consistently fails in breast cancer clinical trials. A new study explains why.

Cancer cells may be using lipids to hide from the immune system

New study demonstrates that one type of lipid is so critical for immune evasion that certain cancers cannot proliferate without them. Modulating intake of dietary lipids could open up an avenue for treatment.

New findings on TB could change how we treat inflammatory disordersÌýÌý Ìý

The study explains why treatments for many autoimmune and inflammatory diseases raise the risk of contracting TB—and also upends long-held assumptions about what kicks off an immune response. ÌýÌýÌý Ìý
View
View